The New Hampshire Supreme Court recently dealt Big Pharma another blow as it challenges the government’s practice of hiring attorneys on a contingency fee basis in litigation accusing the companies of deceptively marketing opioid painkillers.
In a recent spate of lawsuits across the country, plaintiffs lawyers have teamed with state and local governments, suing pharmaceutical companies through contingency fee agreements for their alleged role in creating the prescription opioid and heroin addiction epidemic. Such litigation is pending in federal, state and county courts in Ohio, New York, Mississippi, New Hampshire, Chicago and two California counties.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]